It’s possible that GLP-1s may be useful for a range of substance use disorders, including opioid use disorder and nicotine ...

In a world where alcohol claims nearly 178,000 lives annually in the U.S. alone, a glimmer of hope has emerged from an ...

It's seven o'clock and, like millions of other hard-working women, I feel relief as I pour a glass of chilled Sauvignon. It's ...

A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.

Tom Russell travels frequently, and entertaining is a big part of his job. Planning ahead helped him lose fat and get ...

Each year in the USA, alcohol use contributes to nearly 100 000 new cancer cases and 20 000 deaths from cancer, according to ...

A paper published Wednesday offers the strongest evidence yet that this is more than just anecdote, or a placebo effect: It ...

The blockbuster drug semaglutide, better known as Ozempic for diabetes and Wegovy for obesity, could also help people cut down on their alcohol intake, according to new USC research.

A new study (the first clinical trial of its kind) has shown that the GLP-1 agonist semaglutide — known by the brand name ...